Every bowel movement is rich in information about our digestive health. So, why do we literally flush all that data down the drain? At the 2021 virtual Digestive Disease Week, Duke University gastroenterologist Deborah Fisher, MD, and engineering professor Sonia Grego, PhD, showed that toilets enabled with artificial intelligence can analyze stool samples for signs of acute or chronic gastrointestinal disease, such as bleeding, infections or even inflammatory bowel disease.
Author: Praveen Suthrum
Walmart is making moves to boost its healthcare presence. Here are eight this year for ASC leaders to know: 1. Walmart Health launched a telehealth program for patients with Type 1 and Type 2 diabetes. 2. Walmart blocked prescriptions from clinicians working for telehealth startups to treat ADHD. Telehealth startup Done Health was blocked by Walmart from filling prescriptions after concerns were raised that the startups’ clinicians were writing too many prescriptions for Adderall and other stimulants.
This transcript has been edited for clarity. Hi. I’m Art Caplan, and I’m at the Division of Medical Ethics at New York University’s Grossman School of Medicine. Some of you know that Mark Zuckerberg has spun out a bigger entity of his Facebook company called Meta; what he’s talking about is a company that’s going to try to create an artificial world using the internet in the future — the so-called metaverse.
CARLSBAD, Calif. – May 20, 2022 – (Newswire.com) When it comes to testing new and promising treatments for inflammatory bowel disease, finding the right patients to participate in clinical trials has always been a challenge. Now, in an effort to remove that obstacle, Rhode Island-based University Gastroenterology (UGI) is teaming up with Virgo Surgical Video Solutions (Virgo) out of Carlsbad, California.
A swallowable, vibrating capsule improved symptoms among patients with chronic idiopathic constipation in a phase 3 multicenter, randomized, controlled trial. The method represents a mechanical approach to the treatment of constipation. The swallowable pill acts by vibrating during passage through the gut, where it is thought to augment colonic biorhythm and peristalsis. Traditional treatments for constipation generally increase motility or secretion.
The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer (CRC) revealed a high sensitivity and specificity. At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%. The blood assay detects circulating tumor DNA from cancer in the bloodstream, which is then analyzed for multiple factors, including cancer genetics and methylation.
Thorne HealthTech, a leader in developing innovative solutions for a personalized approach to health and well-being, relaunched its Gut Health Test with the inclusion of its patent-pending Microbiome Wipe, a first-to-market approach to microbiome testing. Thorne’s Microbiome Wipe revolutionizes the user experience of microbiome testing by eliminating inconvenient stool sampling that often leads users to either postpone the test or not take it at all.
Genetic testing has been a game changer in cancer care and prevention, but could we be doing more? Could we use multigene panel testing more broadly to identify both more precise treatments and cancers earlier in patients and their family members? In the study, “Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Amongst a Large Colorectal Cancer Cohort,” presented at Digestive Disease Week 2022, we set out to better understand the potential yield of broadening genetic testing for hereditary cancer risk variants among patients diagnosed with colorectal cancer (CRC).
From May 21-24, more than 3,000 oral and abstract presentations showcasing the latest updates and research were shared at Digestive Disease Week® (DDW) 2022 in San Diego. The event was an amazing opportunity for professionals in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery to reconnect with colleagues, old friends and make new acquaintances after two years apart.
In a recent study published in the American Journal of Gastroenterology, researchers at Cedars-Sinai Medical Center in the United States evaluated an artificial intelligence (AI)-based smartphone application (app) trained to assess a patient’s stool characteristics.